Publications

Health-Related Quality of Life (Hrqol) in Advanced Endometrial Cancer (Aec) Patients (Pts) Treated with Lenvatinib plus Pembrolizumab or Treatment of Physician’s Choice (Tpc).

AuthID
P-00V-TBH

Author(s)

Lorusso, D

Colombo, N

Casado Herraez, A

Santin, A

Colomba, E

Miller, DS

Fujiwara, K

Pignata, S

Baron-Hay, SE

Ray-Coquard, IL

Shapira-Frommer, R

Kim, YM

McCormack, M

Bird, S

Prabhu, VS

Martin Nguyen, A

Zhao, Q

Dutta, L

Makker, V

Document Type

Article

Year published

2021

Published

in Journal of Clinical Oncology, ISSN: 0732-183X

Volume: 39, Issue: 15_suppl, Pages: 5570-5570

Indexing

Crossref^®9

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1200/jco.2021.39.15_suppl.5570

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Health-Related Quality of Life (Hrqol) in Advanced Endometrial Cancer (Aec) Patients (Pts) Treated with Lenvatinib plus Pembrolizumab or Treatment of Physician’s Choice (Tpc).

Useful Links

Get Help

Federated Authentication (Click on the image)

Health-Related Quality of Life (Hrqol) in Advanced Endometrial Cancer (Aec) Patients (Pts) Treated with Lenvatinib plus Pembrolizumab or Treatment of Physician’s Choice (Tpc).

Useful Links

Get Help